About us

Our Advisory Board

Decades of diverse expertise

A remarkable range of career paths converge in this vital source of knowledge, guidance, and foresight for our company. Our Advisory Board includes experts in drug development, clinical care, research and development, real estate, and numerous other industries – along with members of the Vetter family itself.

Together, this exceptional group of leaders provides invaluable input and insight on many of Vetter’s most business-critical decisions, and helps our business navigate the complex dynamics of our every-evolving industry.

Senator h.c. Udo J. Vetter

After studying clinical pharmacy at the University of Washington in Seattle, Mr. Vetter worked for five years as a pharmacist at the pharmaceutical company Schering-Plough Corp. (now Merck & Co Inc.), where he was responsible for setting up production facilities in Puerto Rico. Subsequently, he was Vice President for licensing and production at Martec, Inc., and President of Vetter Pharm-Turm Inc.

Since 1987, he has held various senior management positions at Vetter and has been chairman of the board since 2008. He also established the investment company UV-Cap in 2003. Today, Mr. Vetter is a member of the supervisory board of Gerresheimer AG and of the expert association ISPE. He was also chairman of the university council of the University Albstadt-Sigmaringen until 2018, and received the title of Honorary Senator.

In 2012, he became Vice President of the association Die Familienunternehmer in Germany and, in May 2019, was named President of European Family Businesses (EFB) in Brussels.

Bianca Vetter

Bianca Vetter studied marketing management and foreign languages in London and Paris, and initially worked for a series of German and American companies as sales or executive assistant. Afterwards, Ms. Vetter worked in Administration Management for Dornier, Nortel Dasa, and NDSatcom. Since 2008, she has specialized in furthering technical sports education for young people.

PD Dr. Ute Amann

Dr. Amann studied pharmacy at the Freie Universität Berlin and graduated from Ludwig-Maximilian-University Munich with a Masters in Public Health. After several years in public pharmacies in Germany and New Zealand, she worked as a clinical pharmacist at the university hospitals in Freiburg and Munich, at the Bavarian Association of Statutory Health Insurance Physicians, and also at a company for healthcare data management.

Since then, she has served as one of the scientists at the Leibniz Institute for Prevention Research and Epidemiology, BIPS in Bremen, and at the KORA Myocardial Infarction Registry of the Helmholtz Zentrum München, German Research Center for Environmental Health. She teaches graduate students pursuing their M.Sc. Public Health and M.Sc. Epidemiology, as well as students of Pharmacy at LMU Munich. Since 2003, she has served as an advisor to Vetter on medical and pharmaceutical matters.

Dr. Axel Herberg

Dr. Herberg is a private manager of corporate and real estate investments. From 2010-17, he was a partner with the investment firm Blackstone Group, where he is now a senior advisor.

Prior to joining the Blackstone Group, Dr. Herberg worked as a consultant at McKinsey & Company as well as head of strategic planning at Krupp Industrietechnik. Starting in 1992, he held a number of senior management posts at the packaging specialist Gerresheimer AG, including 10 years as Chief Executive Officer. In 2014, he became a member of the Gerresheimer Group´s Supervisory Board, and was then elected chairman in May 2015.

He has a Ph.D. in business administration, has completed an advanced degree in mechanical engineering, and is also a member of the Supervisory Board of Leica Camera AG.

Prof. Dr. Christof Hettich

An expert in  company and tax law, Prof. Dr. Hettich joined the Mannheim-based law firm Rittershaus in 1990. There, he specialized in corporate structure development and was named partner within three years. Among other roles, he is both a member and chairman of the supervisory boards of several listed companies, as well as founder and managing director of Dievini Hopp Biotech Holding.

Wolfgang Kerkhoff

Mr. Kerkhoff studied business, politics, and journalism in Munich and Montpellier, France. A professional congress organizer since 1984, he organizes medically-focused events throughout Europe for both industry and scientific organizations. Since 1990, he has served as managing partner for Eurokongress, and in 1995, he became the first German citizen to be certified as a congress organizer by the worldwide association MPI. He has been senior partner there since 2012.

Mr. Kerkhoff is also a member of the board of the Munich Congress Alliance and President of Asconet International.

Gert Moelgaard

Mr. Moelgaard has a background as a process automation engineer, and worked at Novo Nordisk and Novo Nordisk Engineering from 1982 to 2016. He has held a range of senior management positions, including Corporate Vice President for Pharmaceutical Engineering, Consulting, and Strategic Development in NNE Pharmaplan A/S.

Since 2016, Mr. Moelgaard has worked as an independent senior consultant at Moelgaard Consulting. He has also been a member or leader of several international committees and expert associations, including ISPE, PDA, ISA and others.

Dr. Susanne Schaffert

Since 1995, Dr. Susanne Schaffert, who holds a PhD in chemistry with honors from the University of Erlangen, served in various leadership positions at Novartis, including Head of Europe Oncology and President and Chair of Accelerated Advanced Applications. At last, she served as President Novartis Oncology and member of the Executive Committee of Novartis, responsible for the global oncology portfolio. Her achievements include the oversight of the first launched CAR-T cell therapy in hematology, to which she has provided access to people in 34 countries, and the launch of the first two radioligand therapies for the treatment of solid tumors in the US and Europe. Twice recognized by Fortune Magazine as one of the "Top 100 Most Powerful Women International," she now serves as an independent member of the boards of directors at Novo Holdings, Galapagos, Incyte as well as ARTBio and contributes her expertise as a member of the Senate Committee on Executive Education at the University of St. Gallen (Switzerland).

Gunther Strothe

Mr. Strothe graduated with an MA in Economics and an MBA from Freiburg/Br. and Fontainebleau. From 1976 to 1990, he worked as a qualified accountant for international accounting firms in both Germany and the USA. He then served as CFO at Hugo Boss AG, as an Investment Banker at Goldman Sachs & Co and, until 2006, as Managing Director for Germany with the international consulting firm Oliver Wyman & Company. Since 1996, he has been a non-executive member of several company boards.